Aclaris aims to raise $96 million through stock offering after shares soar

Shares of the company skyrocketed after announcing positive mid-stage clinical trial results.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.